SHANNON OMAHONEY: Open Payments
NPI 1174912752 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 16 payments from 13 companies in 2025. Trend: 2023 $404 · 2024 $444 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 1 | $53 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $45 |
| Dexcom, Inc. | 1 | $40 |
| Abbott Laboratories | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $32 |
| Mannkind Corporation | 1 | $30 |
| Soleno Therapeutics, Inc. | 1 | $28 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
Products named: iLet Bionic Pancreas, GVOKE HYPOPEN, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, TWIIST, AFREZZA, VYKAT XR, CRYSVITA.
Industry payments across CA — which companies pay providers there.
